Analysis of a range of tumors from small, benign adenomas to large cancers has yielded a robust composite profile in which the first step generally consists of activation of the WNT signaling pathway (mutated in ∼93 % of CRCs), commonly via mutation of the APC (Adenomatous Polyposis Coli) tumor suppressor gene [11,15]. This evidence concerns the gene APC and cancer.